Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis

Rift Valley fever (RVF) is an emerging arboviral disease affecting both humans and livestock. In humans, RVF displays a spectrum of clinical manifestations, including encephalitis. To date, there are no FDA-approved vaccines or therapeutics for human use, although several are in preclinical developm...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kaleigh A. Connors, Nathaniel S. Chapman, Cynthia M. McMillen, Ryan M. Hoehl, Jackson J. McGaughey, Zachary D. Frey, Morgan Midgett, Connor Williams, Douglas S. Reed, James E. Crowe Jr., Amy L. Hartman
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical investigation 2024-09-01
Edice:	JCI Insight
Témata:	Immunology Infectious disease
On-line přístup:	https://doi.org/10.1172/jci.insight.180151
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!